Sugyo A, Tsuji A, Sudo H, Sugiura Y, Koizumi M, Higashi T. Wnt1 induces osteoblastic changes in a well-established osteolytic skeletal metastatic model derived from breast cancer. Cancer Rep (Hoboken). 2023;6:e1909 pubmed publisher

VanderVorst K, Dreyer C, Hatakeyama J, Bell G, Learn J, Berg A, et al. Vangl-dependent Wnt/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis. Breast Cancer Res. 2023;25:52 pubmed publisher

Ning S, Liu C, Lou W, Yang J, Lombard A, D Abronzo L, et al. Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Mol Cancer Ther. 2022;21:1594-1607 pubmed publisher

Ragab N, Bauer J, Uhmann A, Marx A, Hahn H, Simon Keller K. Tumor suppressive functions of WNT5A in rhabdomyosarcoma. Int J Oncol. 2022;61: pubmed publisher

Chmielowiec J, Szlachcic W, Yang D, Scavuzzo M, Wamble K, Sarrión Perdigones A, et al. Human pancreatic microenvironment promotes β-cell differentiation via non-canonical WNT5A/JNK and BMP signaling. Nat Commun. 2022;13:1952 pubmed publisher

Glaeser K, Urban M, Fenech E, Voloshanenko O, Kranz D, Lari F, et al. ERAD-dependent control of the Wnt secretory factor Evi. EMBO J. 2018;37: pubmed publisher

Wald J, Hatakeyama J, Printsev I, Cuevas A, Fry W, Saldana M, et al. Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene. 2017;36:5158-5167 pubmed publisher

Najdi R, Proffitt K, Sprowl S, Kaur S, Yu J, Covey T, et al. A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation. 2012;84:203-13 pubmed publisher